FDA Clearance Tracker · DEN200011
Masimo SafetyNet
Last checked: Nov 20, 2026Latest source record: Mar 31, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Mar 31, 2023
De Novo granted
Time to decision
1,136 days
Received Feb 19, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN200011
- Device name
- Masimo SafetyNet
- Applicant
- Masimo Corporation
- Applicant location
- Irvine, CA
- Received
- Feb 19, 2020
- Decided
- Mar 31, 2023
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 868.2250
- Specialty
- Anesthesiology & Respiratory
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
- FDA database record for DEN200011
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Masimo Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260676 · Decided Oct 14, 2026 · 226 days after receipt
Device type: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms) (MHX) · Cardiology
K253417 · Decided Aug 12, 2026 · 315 days after receipt
Device type: Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms) (MWI) · Cardiology
- SedLine Sedation Monitor510(k)
K260880 · Decided Jul 10, 2026 · 115 days after receipt
Device type: Index-Generating Electroencephalograph Software (OLW) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.